Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
Clinical trial NCT04532294 · COMPLETED
Trial details
- NCT number
- NCT04532294
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2021-02-13
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.